Clinical Trials · NCT04731272
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Pennsylvania
- Enrollment
- 30
- Start date
- Jul 2021
- Locations
- 2 sites, United States
- Primary endpoint
- Early-phase insulin secretion